AMCR vs PRCT · P/E 18, rev $23.51B vs rev $177.6M
Amcor PLC (AMCR) versus Procept Biorobotics Corp (PRCT) — a side-by-side from cached financials, not a winner call.
Amcor PLC (AMCR) is a packaging & containers company listed on US.
Procept Biorobotics Corp (PRCT) is a medical devices company listed on US.
Latest reported AMCR revenue for 2026-06-30 was $23.51B. Net income was $1.11B. Revenue was up 362.5% from 2025-06-30 to 2026-06-30. AMCR currently screens at market cap $22.52B and trailing P/E 17.6.
Latest reported PRCT revenue for 2026-06-30 was $177.6M. Net income was -$58.5M. PRCT currently screens at market cap $1.52B.
AMCR currently screens at market cap $22.52B and trailing P/E 17.6. PRCT currently screens at market cap $1.52B.
Not investment advice. Open the AMCR and PRCT stock pages for the full models.
Not investment advice.